Podcast: Charting the next chapter in obesity therapeutics
Obesity is a complex, chronic disease affecting hundreds of millions of people across diverse populations. Recent advances in incretin biology…
Obesity is a complex, chronic disease affecting hundreds of millions of people across diverse populations. Recent advances in incretin biology…
Obesity is a chronic disease defined by excessive fat accumulation, typically diagnosed by a body mass index (BMI) of ≥30,…
A new report from leading contract research organisation Novotech has shed light on the current state of play in the…
Artificial intelligence (AI) is set to be the most disruptive emerging technology in drug development in 2023, unlocking advanced analytics,…
Due to its geographic proximity with China, South Korea was one of the first locations hit with the Covid-19 viral…
Clinical development in oncology and immunotherapies has accelerated dramatically over the past few years. As of December 2019, over 6,000…
The regulatory environment in Australia and New Zealand offers a significant strategic opportunity for international biotech companies wanting a fast…